{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:49:41Z","timestamp":1761828581040,"version":"build-2065373602"},"reference-count":57,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000052","name":"NIH Office of the Director","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000052","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005189","name":"Leukemia and Lymphoma Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000055","name":"National Institute on Deafness and Other Communication Disorders","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000055","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","translationalres.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Translational Research"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/j.trsl.2019.08.008","type":"journal-article","created":{"date-parts":[[2019,8,28]],"date-time":"2019-08-28T02:12:53Z","timestamp":1566958373000},"page":"31-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A comprehensive, multidisciplinary, precision medicine approach to discover effective therapy for an undiagnosed, progressive, fibroinflammatory disease"],"prefix":"10.1016","volume":"215","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4727-8918","authenticated-orcid":false,"given":"Bernadette R.","family":"Gochuico","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shira G.","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas S.","family":"Ten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicholas J.","family":"Balanda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1850-1642","authenticated-orcid":false,"given":"Christopher E.","family":"Mason","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Zumbo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colleen A.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carter","family":"Van Waes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William A.","family":"Gahl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"May C.V.","family":"Malicdan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.trsl.2019.08.008_bib0001","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nrc.2016.126","article-title":"Consensus molecular subtypes and the evolution of precision medicine in colorectal cancer","volume":"17","author":"Dienstmann","year":"2017","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/j.trsl.2019.08.008_bib0002","doi-asserted-by":"crossref","first-page":"e175","DOI":"10.1016\/S1470-2045(19)30026-9","article-title":"Immunotherapy and targeted therapy combinations in metastatic breast cancer","volume":"20","author":"Esteva","year":"2019","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.trsl.2019.08.008_bib0003","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/nature25183","article-title":"The biology and management of non-small cell lung cancer","volume":"553","author":"Herbst","year":"2018","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2019.08.008_bib0004","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1056\/NEJMoa011573","article-title":"Hematologic and cytogenetic responses to imatinib mesylate in chronic myelogenous leukemia","volume":"346","author":"Kantarjian","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2019.08.008_bib0005","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.trsl.2015.04.008","article-title":"Translating the genetics of cystic fibrosis to personalized medicine","volume":"168","author":"Corvol","year":"2016","journal-title":"Transl Res"},{"key":"10.1016\/j.trsl.2019.08.008_bib0006","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","article-title":"Burosumab therapy in children with X-linked hypophosphatemia","volume":"378","author":"Carpenter","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2019.08.008_bib0007","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1182\/blood-2012-07-446286","article-title":"Dramatic efficacy of vemurafenib in both multisystemic and refractory erdheim-chester disease and langerhans cell histiocytosis harboring the BRAF V600E mutation","volume":"121","author":"Haroche","year":"2013","journal-title":"Blood"},{"key":"10.1016\/j.trsl.2019.08.008_bib0008","first-page":"384","article-title":"Vemurafenib for BRAF V600-Mutant Erdheim-Chester disease and langerhans cell histiocytosis: analysis of data from the histology-independent, phase 2, open-label VE-BASKET study","volume":"4","author":"Diamond","year":"2018","journal-title":"J Am Med Assoc Oncol"},{"key":"10.1016\/j.trsl.2019.08.008_bib0009","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1056\/NEJMoa1510198","article-title":"Treatment of Fabry's disease with the pharmacologic chaperone migalastat","volume":"375","author":"Germain","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2019.08.008_bib0010","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1716153","article-title":"Patisiran, an RNAi therapeutic, for hereditary transthyretin amyloidosis","volume":"379","author":"Adams","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2019.08.008_bib0011","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1056\/NEJMoa1716793","article-title":"Treatment for patients with hereditary transthyretin amyloidosis","volume":"379","author":"Benson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2019.08.008_bib0012","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.trsl.2009.03.008","article-title":"Drug development for orphan diseases in the context of personalized medicine","volume":"154","author":"Brewer","year":"2009","journal-title":"Transl Res"},{"key":"10.1016\/j.trsl.2019.08.008_bib0013","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1001\/jama.2011.613","article-title":"The NIH undiagnosed diseases program: lessons learned","volume":"305","author":"Gahl","year":"2011","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.trsl.2019.08.008_bib0014","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.ymgme.2016.01.007","article-title":"The NIH undiagnosed diseases program and network: applications to modern medicine","volume":"117","author":"Gahl","year":"2016","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.trsl.2019.08.008_bib0015","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1001\/jama.2015.12249","article-title":"The undiagnosed diseases network of the National Institutes of Health: a national extension","volume":"314","author":"Gahl","year":"2015","journal-title":"J Am Med Assoc"},{"key":"10.1016\/j.trsl.2019.08.008_bib0016","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.ajhg.2017.01.006","article-title":"The undiagnosed diseases network: accelerating discovery about health and disease","volume":"100","author":"Ramoni","year":"2017","journal-title":"Am J Hum Genet"},{"key":"10.1016\/j.trsl.2019.08.008_bib0017","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1056\/NEJMoa1714458","article-title":"Effect of genetic diagnosis on patients with previously undiagnosed disease","volume":"379","author":"Splinter","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2019.08.008_bib0018","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.ymgme.2016.08.009","article-title":"Identification of a novel mutation in HPS6 in a patient with hemophilia B and oculocutaneous albinism","volume":"119","author":"O'Brien","year":"2016","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.trsl.2019.08.008_bib0019","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1165\/rcmb.2013-0025OC","article-title":"Dysregulation of Galectin-3. Implications for hermansky-pudlak syndrome pulmonary fibrosis","volume":"50","author":"Cullinane","year":"2014","journal-title":"Am J Respir Cell Mol Biol"},{"key":"10.1016\/j.trsl.2019.08.008_bib0020","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.ymgme.2017.02.007","article-title":"Clinical and molecular phenotyping of a child with Hermansky-Pudlak Syndrome-7, an uncommon genetic type of HPS","volume":"120","author":"Bryan","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/j.trsl.2019.08.008_bib0021a","doi-asserted-by":"crossref","first-page":"e59190","DOI":"10.1371\/journal.pone.0059190","article-title":"Compression of FASTQ and SAM format sequencing data","volume":"8","author":"Bonfield","year":"2013","journal-title":"PLOS One"},{"key":"10.1016\/j.trsl.2019.08.008_bib0021b","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.1093\/nar\/gkp1137","article-title":"The Sanger FASTQ file format for sequences with quality scores, and the Solexa\/Illumina FASTQ variants","volume":"38","author":"Cock","year":"2010","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.trsl.2019.08.008_bib0022","unstructured":"Andrews S. FastQC: a quality control tool for high throughput sequence data. http:\/\/www.bioinformatics.babraham.ac.uk\/projects\/fastqc\/."},{"key":"10.1016\/j.trsl.2019.08.008_bib0023","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.trsl.2019.08.008_bib0024","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","article-title":"STAR: ultrafast universal RNA-seq aligner","volume":"29","author":"Dobin","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.trsl.2019.08.008_bib0025","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.1101\/gr.135350.111","article-title":"GENCODE: the reference human genome annotation for the ENCODE project","volume":"22","author":"Harrow","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/j.trsl.2019.08.008_bib0026","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1093\/bioinformatics\/btt656","article-title":"FeatureCounts: an efficient general purpose program for assigning sequence reads to genomic features","volume":"30","author":"Liao","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.trsl.2019.08.008_bib0027","doi-asserted-by":"crossref","first-page":"D733","DOI":"10.1093\/nar\/gkv1189","article-title":"Reference sequence (RefSeq) database at NCBI: current status, taxonomic expansion, and functional annotation","volume":"44","author":"O'Leary","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.trsl.2019.08.008_bib0028","doi-asserted-by":"crossref","first-page":"D61","DOI":"10.1093\/nar\/gkl842","article-title":"NCBI reference sequences (RefSeq): a curated non-redundant sequence database of genomes, transcripts and proteins","volume":"35","author":"Pruitt","year":"2007","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.trsl.2019.08.008_bib0029","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0157022","article-title":"SARTools: a DESeq2- and EdgeR-based R pipeline for comprehensive differential analysis of RNA-Seq data","volume":"11","author":"Varet","year":"2016","journal-title":"PLOS One"},{"key":"10.1016\/j.trsl.2019.08.008_bib0030","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1186\/s13059-014-0550-8","article-title":"Moderated estimation of fold change and dispersion for RNA-seq data with DESeq2","volume":"15","author":"Love","year":"2014","journal-title":"Genome Biol"},{"key":"10.1016\/j.trsl.2019.08.008_bib0031","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc"},{"key":"10.1016\/j.trsl.2019.08.008_bib0032","unstructured":"Blighe, K. Enhanced Volcano: Publication-ready volcano plots with enhanced colouring and labeling. https:\/\/github.com\/kevinblighe. 2018."},{"key":"10.1016\/j.trsl.2019.08.008_bib0033","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","article-title":"Causal analysis approaches in ingenuity pathway analysis","volume":"30","author":"Kr\u00e4mer","year":"2014","journal-title":"Bioinformatics"},{"key":"10.1016\/j.trsl.2019.08.008_bib0034","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1093\/nar\/28.1.27","article-title":"KEGG: kyoto encyclopedia of genes and genomes","volume":"28","author":"Kanehisa","year":"2000","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.trsl.2019.08.008_bib0035","doi-asserted-by":"crossref","first-page":"D457","DOI":"10.1093\/nar\/gkv1070","article-title":"KEGG as a reference resource for gene and protein annotation","volume":"44","author":"Kanehisa","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.trsl.2019.08.008_bib0036","doi-asserted-by":"crossref","first-page":"D353","DOI":"10.1093\/nar\/gkw1092","article-title":"KEGG: new perspectives on genomes, pathways, diseases and drugs","volume":"45","author":"Kanehisa","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/j.trsl.2019.08.008_bib0037","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1093\/bioinformatics\/btt285","article-title":"Pathview: an R\/bioconductor package for pathway-based data integration and visualization","volume":"29","author":"Luo","year":"2013","journal-title":"Bioinformatics"},{"key":"10.1016\/j.trsl.2019.08.008_bib0038","first-page":"55","article-title":"Chloroquine and hydroxychloroquine equally affect tumor necrosis factor-alpha, interleukin 6, and interferon-gamma production by peripheral blood mononuclear cells","volume":"24","author":"van den Borne","year":"1997","journal-title":"J Rheumatol"},{"key":"10.1016\/j.trsl.2019.08.008_bib0039","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1046\/j.0019-2805.2001.01339.x","article-title":"Chloroquine decreases cell-surface expression of tumour necrosis factor receptors in human histiocytic U-937 cells","volume":"105","author":"Jeong","year":"2002","journal-title":"Immunology"},{"key":"10.1016\/j.trsl.2019.08.008_bib0040","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.intimp.2018.08.008","article-title":"Attenuation of antimalarial agent hydroxychloroquine on TNF-\u03b1-induced endothelial inflammation","volume":"63","author":"Li","year":"2018","journal-title":"Int Immunopharmacol"},{"key":"10.1016\/j.trsl.2019.08.008_bib0041","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1038\/jid.2009.80","article-title":"Hydroxychloroquine modulates metabolic activity and proliferation and induces autophagic cell death of human dermal fibroblasts","volume":"129","author":"Ramser","year":"2009","journal-title":"J Investig Dermatol"},{"key":"10.1016\/j.trsl.2019.08.008_bib0042","first-page":"262","article-title":"Pentoxifylline in vivo down-regulates the release of IL-1 Beta, IL-6, IL-8 and tumour necrosis factor-alpha by human peripheral blood mononuclear cells","volume":"83","author":"Neuner","year":"1994","journal-title":"Immunology"},{"key":"10.1016\/j.trsl.2019.08.008_bib0043","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1159\/000350132","article-title":"Impact of sunitinib on human thyroid cancer cells","volume":"32","author":"Grosse","year":"2013","journal-title":"Cell Physiol Biochem"},{"key":"10.1016\/j.trsl.2019.08.008_bib0044","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1056\/NEJMoa0912923","article-title":"NT5E mutations and arterial calcifications","volume":"364","author":"St Hilaire","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2019.08.008_bib0045","article-title":"Expanding the phenotype of COPA syndrome: a kindred with typical and atypical features","author":"Taveira-DaSilva","year":"2018","journal-title":"J Med Genet"},{"key":"10.1016\/j.trsl.2019.08.008_bib0046","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1038\/nature05945","article-title":"Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer","volume":"448","author":"Soda","year":"2007","journal-title":"Nature"},{"key":"10.1016\/j.trsl.2019.08.008_bib0047","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1704795","article-title":"Alectinib versus crizotinib in untreated ALK-positive non-small-cell lung cancer","volume":"377","author":"Peters","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2019.08.008_bib0048","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1105185","article-title":"A CFTR potentiator in patients with cystic fibrosis and the G551D mutation","volume":"365","author":"Ramsey","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2019.08.008_bib0049","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1056\/NEJMoa1409547","article-title":"Lumacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del CFTR","volume":"373","author":"Wainwright","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2019.08.008_bib0050","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1056\/NEJMoa1709846","article-title":"Tezacaftor-ivacaftor in patients with cystic fibrosis homozygous for Phe508del","volume":"377","author":"Taylor-Cousar","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2019.08.008_bib0051","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.1056\/NEJMoa1807119","article-title":"VX-659-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles","volume":"379","author":"Davies","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2019.08.008_bib0052","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1056\/NEJMoa1807120","article-title":"VX-445-tezacaftor-ivacaftor in patients with cystic fibrosis and one or two Phe508del alleles","volume":"379","author":"Keating","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/j.trsl.2019.08.008_bib0053","first-page":"1453","article-title":"The Risk of Toxic retinopathy in patients on long-term hydroxychloroquine therapy","volume":"132","author":"Melles","year":"2014","journal-title":"J Am Med Assoc Ophthalmol"},{"key":"10.1016\/j.trsl.2019.08.008_bib0054","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1097\/BOR.0000000000000500","article-title":"Hydroxychloroquine: balancing the need to maintain therapeutic levels with ocular safety: an update","volume":"30","author":"Abdulaziz","year":"2018","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/j.trsl.2019.08.008_bib0055","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/gim.0b013e318232a005","article-title":"The NIH undiagnosed diseases program: insights into rare diseases","volume":"14","author":"Gahl","year":"2012","journal-title":"Genet Med"},{"key":"10.1016\/j.trsl.2019.08.008_bib0056","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2017.7112","article-title":"Risks of breast, ovarian, and contralateral breast cancer for BRCA1 and BRCA2 mutation carriers","volume":"317","author":"Kuchenbaecker","year":"2017","journal-title":"J Am Med Assoc"}],"container-title":["Translational Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524419301719?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1931524419301719?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T12:39:28Z","timestamp":1761827968000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1931524419301719"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1]]},"references-count":57,"alternative-id":["S1931524419301719"],"URL":"https:\/\/doi.org\/10.1016\/j.trsl.2019.08.008","relation":{},"ISSN":["1931-5244"],"issn-type":[{"type":"print","value":"1931-5244"}],"subject":[],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A comprehensive, multidisciplinary, precision medicine approach to discover effective therapy for an undiagnosed, progressive, fibroinflammatory disease","name":"articletitle","label":"Article Title"},{"value":"Translational Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.trsl.2019.08.008","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}